<div class="bodytext_module_container"> <div class="bodytext_module_body"> <p>Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in Lp(a) presented at the ACC 25.</p> </div> </div> <div class="bodytext_module_container"> <div class="bodytext_module_body"> <p> </p> <p><strong>VIEW THE TOPICS</strong></p> <ul> <li>Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor Treatment on Lp(a)</li> <li>Novel Therapeutic Agents for Managing Elevated Lp(a) Levels</li> <li>Present and Future Management of Dyslipidemia</li> <li>Role of Lp(a) in Atherosclerotic Cardiovascular Disease</li> </ul> <p> </p> <p><em>This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American College of Cardiology.</em></p> </div> </div>